Robotic Cancer Surgery in Raipur

Robotic cancer surgery is a form of minimally invasive surgery in which the surgeon controls a robotic system, using highly articulated instruments that move with a precision exceeding what the human hand achieves in conventional laparoscopy. The robot translates every movement the surgeon makes with tremor filtration and motion scaling into precise instrument movement inside the patient.

The system works through small ports of 8 to 12 mm through which robotic arms and a high-definition camera are inserted. The surgeon views a magnified, three-dimensional operative field and controls wristed instruments capable of seven degrees of freedom (far exceeding the range of conventional laparoscopic instruments). This combination of visualisation and dexterity allows complex dissections in anatomically confined spaces – the pelvis, retroperitoneum, and mediastinum/thorax – giving meticulous results.

For cancer surgery the robotic platform enables sharper tissue plane dissection with lower blood loss, more precise lymph node clearance around major vessels and the ability to perform intracorporeal anastomoses with dexterity difficult to replicate through conventional modalities. 

Why Choose Ramkrishna CARE Hospitals for Robotic Cancer Surgery in Raipur?

Ramkrishna CARE Hospitals combines advanced robotic technology with the expertise of experienced cancer specialists to provide precise, minimally invasive cancer surgery tailored to each patient's needs:

• Subspeciality-trained surgical oncologists: Robotic cancer surgery at Ramkrishna CARE Hospitals is performed by surgical oncologists with formal training across urological, gastrointestinal, gynaecological and thoracic oncological surgery.
• Multidisciplinary tumour board review: Every patient considered for surgery is reviewed before the operative approach is decided. Surgical strategy is informed by PET-CT staging from the uMI 550, pathological and molecular data and input from medical and radiation oncology.
• PET CT surgical planning: pre-operative PET CT on the uMI 550 Digital PET CT maps primary tumour extent, nodal involvement and distant spread before surgery. The system's 2.76mm crystal pixel resolution and time-of-flight imaging identify occult metastases that would upstage the patient, preventing unnecessary major operations.
• Integrated treatment planning: Robotic surgery is the surgical component of a comprehensive treatment plan. Pre- and post-operative neo-adjuvant chemotherapy, precision radiation therapy on the Elekta Versa HD and structured oncological surveillance are part of the same programme managed by the same multidisciplinary team.
• HD Endovision and 3D laparoscopy: our operating theatres are equipped with HD Endovision and 3D laparoscopy, providing the magnified, depth-perceiving operative view that complex cancer dissections require. 

Conditions Treated with Robotic Cancer Surgery

Robotic cancer surgery is used for a wide range of cancers where greater surgical precision and a minimally invasive approach can improve treatment outcomes and recovery:

• Urological cancers: Radical prostatectomy for prostate cancer, radical and partial nephrectomy for renal cell carcinoma and radical cystectomy with urinary diversion for bladder cancer/neo-bladder.
• Gastrointestinal cancers: Colectomy for colorectal cancer, low anterior resection for rectal cancer (where the confined pelvis makes robotic access particularly advantageous), gastrectomy for gastric cancer, 6 small bowel tumour oesophageal procedures
• Gynaecological cancers: Radical hysterectomy with pelvic lymph node dissection for cervical & endometrial cancer and staging surgery for ovarian cancer
• Thoracic tumours: Robotic-assisted lobectomy and segmentectomy for early-stage lung cancer with precision in mediastinal lymph node dissection
• Hepatobiliary and adrenal: Selected liver resections, pancreatic procedures and adrenalectomy for adrenal tumours, including phaeochromocytoma.
• Head, neck and thyroid: Robotic thyroidectomy avoiding a neck scar and transoral robotic surgery (TORS) for oropharyngeal tumours resected through the mouth without external incision.

Who is a Candidate for Robotic Cancer Surgery?

Candidacy is determined by the tumour stage and resectability, patient anatomy and the surgical team's assessment. General criteria include the following:

• Cancer confined to or around the primary organ, without distant metastases making local resection appropriate
• Medical fitness for general anaesthesia and a minimally invasive procedure
• Absence of extensive prior abdominal or pelvic surgery creating adhesions that would limit safe port placement
• Tumour size and location within the range for which robotic technique offers advantages

Robotic surgery is not appropriate for every patient or tumour. At Ramkrishna CARE Hospitals, the decision is made at a multidisciplinary tumour board by surgical oncologists committed to the right guidelines and specific treatment protocols.

Symptoms That May Lead to Robotic Cancer Surgery

Robotic surgery is indicated by cancer diagnosis and stage. Presentations commonly leading to surgical evaluation and potential robotic resection are:

• Prostate cancer confirmed on biopsy, particularly localised disease suitable for radical prostatectomy
• Rectal bleeding or bowel habit change leading to colonoscopy and colorectal cancer diagnosis
• Abnormal uterine bleeding in endometrial cancer or cervical pathology on biopsy
• Haematuria diagnosed as bladder cancer, requiring cystectomy
• A renal mass on imaging meeting criteria for surgical resection
• A pulmonary nodule that is growing or metabolically active on PET-CT in a surgically fit patient.

Diagnosis and Pre-Surgical Assessment

Robotic cancer surgery is planned on the basis of accurate staging. The pre-operative workup includes histological confirmation of malignancy; CT and MRI tailored to the tumour site; and, where clinically indicated, PET-CT on the uMI 550 Digital PET-CT system.

PET-CT is particularly valuable before major cancer surgery when resectability depends on the absence of distant spread. The uMI 550's 2.76 mm resolution and time-of-flight imaging identify occult metastases with greater sensitivity than CT alone, preventing futile surgery in patients with disease beyond what resection can address. For confirmed resectable disease, PET/CT-defined tumour extent guides the surgical team in planning dissection boundaries and lymph node clearance required for adequate oncological margins, and it helps in postoperative follow-up.

Risks

Possible complications are the following:

• General surgical risks: Like any major surgery, robotic surgery has several surgical complications, like bleeding, infection, anaesthetic complications, thromboembolic events and injury to adjacent structures, but generally at lower rates than the open technique.
• Conversion to open surgery: In a small proportion of cases, anatomical findings or unexpected bleeding leads the surgeon to convert to open surgery intraoperatively.
• Oncological risks: Positive resection margins, incomplete lymph node clearance and the possibility of microscopic residual disease requiring adjuvant chemotherapy or radiation therapy are lower in robotic surgery owing to better precision.
• Site-specific complications: Urinary incontinence and erectile dysfunction after radical prostatectomy; anastomotic leak after colorectal resection; lymphoedema after pelvic lymph node dissection – present with both open and robotic surgery (generally at a lower frequency with the robotic technique).

Benefits of Robotic Cancer Surgery

Key advantages are:

• Smaller incisions: Four to six ports of 8 to 12 mm versus a 15 to 25 cm open incision, with significantly reduced wound pain and lower wound complication rates
• Less blood loss: Magnified visualisation and precise instrument control enable dissection closer to tissue planes than open surgery in most robotic procedures.
• Faster recovery: Shorter hospital stays and faster returns to normal activity are consistent findings across robotic versus open surgical comparisons for most cancer types.
• Superior access in confined spaces: a 3D magnified view and wristed instrument motion allow dissection in the pelvis, retroperitoneum and mediastinum with clarity that conventional laparoscopy & sometimes open surgery cannot match.
• Tremor filtration and motion scaling: The robotic system filters hand tremor and scales movements, improving precision in delicate dissections around nerves and major vessels.
• Nerve-sparing precision: Enhanced visualisation and wrist instruments improve the surgeon's ability to spare the neurovascular bundles controlling urinary & sexual function in prostate and pelvic cancer surgery.
• Lower wound complication rate: Consistent across multiple clinical studies comparing robotic and open surgery for prostatectomy, colectomy and hysterectomy

Conclusion

Robotic cancer surgery represents the current frontier of minimally invasive oncological surgery, combining the precision advantages of advanced surgical technology with the reduced recovery burden of small-access surgery. For appropriate candidates, it offers genuine clinical advantages over conventional open surgery in blood loss, recovery and functional outcomes such as urinary continence after prostate surgery.

At Ramkrishna CARE Hospitals, Raipur, robotic cancer surgery is the surgical component of a complete oncological programme: preceded by accurate PET-CT staging on the uMI 550, guided by a multidisciplinary tumour board and followed by adjuvant therapy on the Elekta Versa HD or systemic treatment as required. For patients across Chhattisgarh seeking advanced surgical oncology, this integrated capability is available here.